GARACI, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 57.046
EU - Europa 5.362
AS - Asia 1.736
Continente sconosciuto - Info sul continente non disponibili 27
SA - Sud America 19
OC - Oceania 13
AF - Africa 8
Totale 64.211
Nazione #
US - Stati Uniti d'America 57.002
CN - Cina 1.359
UA - Ucraina 1.010
DE - Germania 818
IT - Italia 634
FR - Francia 631
PL - Polonia 580
IE - Irlanda 568
SE - Svezia 420
GB - Regno Unito 281
KR - Corea 219
FI - Finlandia 211
RU - Federazione Russa 103
IN - India 41
BE - Belgio 39
CA - Canada 36
JP - Giappone 33
EU - Europa 24
ES - Italia 19
UZ - Uzbekistan 18
SG - Singapore 14
IL - Israele 13
AU - Australia 12
NL - Olanda 12
VN - Vietnam 12
CL - Cile 8
IR - Iran 8
HK - Hong Kong 7
BR - Brasile 6
CH - Svizzera 6
MX - Messico 6
AT - Austria 5
DK - Danimarca 5
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
GR - Grecia 3
KG - Kirghizistan 3
AL - Albania 2
DM - Dominica 2
DZ - Algeria 2
EG - Egitto 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
HU - Ungheria 1
ID - Indonesia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 64.211
Città #
Woodbridge 17.967
Wilmington 15.054
Houston 13.973
Ann Arbor 1.925
Fairfield 1.327
Chandler 1.001
Jacksonville 944
Ashburn 723
Kraków 574
Dublin 563
Seattle 524
Zhengzhou 501
Cambridge 453
Medford 446
Beijing 386
Dearborn 357
Rome 229
Lawrence 203
Mülheim 164
Shanghai 112
New York 99
Menlo Park 91
San Diego 90
Boardman 86
Hangzhou 80
San Mateo 64
Falls Church 63
Milan 63
Mountain View 42
University Park 42
Brussels 39
Guangzhou 34
Hefei 34
Redwood City 34
Nanjing 32
Toronto 32
Norwalk 31
London 30
Verona 28
Kunming 26
Palo Alto 25
Saint Petersburg 19
Auburn Hills 16
Los Angeles 15
Nürnberg 15
Jinan 14
Nanchang 12
Detroit 11
Indiana 11
Portici 11
Changsha 10
Chicago 10
Helsinki 10
Washington 10
Chengdu 9
Florence 9
Haikou 9
Creede 8
Hanoi 8
Pune 8
Chongqing 7
Fuzhou 7
Hong Kong 6
Kilburn 6
Lappeenranta 6
Madrid 6
Marano Di Napoli 6
Simi Valley 6
Tappahannock 6
Hebei 5
Napoli 5
San Francisco 5
Stockholm 5
Torino 5
Cagliari 4
Camerino 4
Catanzaro 4
Guidonia 4
Gurgaon 4
Hounslow 4
Phoenix 4
Shenyang 4
Vienna 4
Xian 4
Ahmedabad 3
Alghero 3
Andover 3
Aversa 3
Baotou 3
Bologna 3
Buffalo 3
Catania 3
Chiswick 3
Dong Ket 3
Genoa 3
Groningen 3
Las Vegas 3
Ludhiana 3
Monterotondo 3
Naples 3
Totale 58.875
Nome #
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 480
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 480
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer 475
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 472
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 471
Thymosin alpha 1: From bench to bedside 470
Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier 468
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 465
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1. 453
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 453
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 445
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 441
Effect of combined alpha IFN and prostaglandin A(1) treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells 440
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 436
Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2 436
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis. 436
Intracellular GSH content and HIV replication in human macrophages 434
INHIBITION OF RAT FIBROBLAST CELL-PROLIFERATION AT SPECIFIC CELL-CYCLE STAGES BY COCAINE 433
Fluconazole resistance in Candida albicans: A review of mechanisms 431
Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply 431
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 429
ANTIVIRAL ACTIVITY OF CYCLOPENTENONE PROSTAGLANDINS - BLOCK OF VIRUS PROTEIN-SYNTHESIS AND INDUCTION OF STRESS PROTEINS IN POLARIZED MONKEY KIDNEY-CELLS 428
Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4(+) and CD8(+) T cells 427
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 426
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 426
Inhibition of influenza A virus replication by resveratrol 425
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 423
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 423
Thymosin alpha 1: from bench to bedside 418
PCT (WO/2006/069812) RETROTRANSPOSON INHIBITION IN THERAPY 418
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 417
Fluconazole resistance in Candida albicans: a review of mechanisms. 417
Human endogenous retroviruses and ADHD 416
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 415
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 413
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 413
Combination therapy with BRMs in cancer and infectious diseases 410
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV 410
Influence of cocaine on murine immune surveillance. 409
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 408
Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus 407
Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells. 406
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 406
Treatment of aspergillus infection with thymosin alpha 1 406
activation of human endogenous retrovirus k and cellular modifications in human melanoma cell line: gene expression analysis 405
Analisi dell’espressione di retrovirus endogeni umani (HERV) in linfomonociti di soggetti sani di varie eta’: indicazioni per un possibile ruolo nello sviluppo 405
Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains 404
In vivo recovery of natural killer cell activity by the association of thymosin α1 and cytokines during cocaine administration 399
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 398
Adhd and human endogenous retroviruses 398
Herpesviruses and periodontal disease: a cautionary tale 398
Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice 397
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 397
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 397
Thymosin α1 and cancer: action on immune effector and tumor target cells 396
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression 395
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 395
Activation of human endogenous retrovirus k (herv-k) and cellular modifications in a human melanoma cell line: trascriptional profiling analysis 395
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 394
Analisi filogenetica di un isolato di herv-k ottenuto da una lesione di melanoma metastatico umano. 394
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 393
Ruolo eziopatogenetico dei retrovirus endogeni umani: il caso del melanoma 392
Effect of thymosin alpha 1 on cocaine-induced inhibition of T cell dependent murine immune response. 383
Glutathione inhibits HIV replication by acting at late stages of the virus life cycle 382
Thymosin alpha 1 as a stimulatory agent of innate cell-mediated immune response 382
Modulatory role of PGE2 on IL-2 production after in vivo treatment. 382
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS K AND CELLULAR MODIFICATIONS IN HUMAN MELANOMA CELL LINE: GENE EXPRESSION ANALYSIS. 382
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes 381
Thymosin αlpha1 potentiatesthe release of antiviral factors by cd8+ cells: new tools for antiviral therapy 381
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 380
Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis 380
INFLUENZA DEL MICROAMBIENTE SULLA PLASTICITA’ DI CELLULE DI MELANOMA ESPRIMENTI HERV-K. 380
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 379
Depressed T-cell proliferation and polymorphonuclear superoxide anion production in mice treated with cocaine 378
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration 377
null 376
thymosin alpha1 activates the tlr9/myd88/irf7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo 376
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 376
Anti-tumour immunogens and vaccines 375
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 374
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 373
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 373
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 372
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. 372
Inibitori Delle Istone Deacetilasi Riattivano Il Retrovirus Endogeno Umano-K In Cellule Di Melanoma Umano 372
Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection 370
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 370
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 370
Cocaine effects on cell-cycle progression. 368
MiR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes 368
New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity 368
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 367
Combination therapy with BRMs in cancer and infectious diseases 367
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 366
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 366
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 365
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 365
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 364
THYMOSIN ALPHA-1 RESTORES MURINE T-CELL-MEDIATED RESPONSES INHIBITED BY INVIVO COCAINE ADMINISTRATION 361
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 361
Totale 40.380
Categoria #
all - tutte 108.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.141 0 0 0 0 0 0 0 0 0 0 1.669 1.472
2019/202016.577 1.463 1.352 1.231 1.531 1.317 1.773 1.501 1.498 1.312 1.313 1.020 1.266
2020/20219.938 1.073 1.253 1.081 1.240 947 1.073 1.274 975 317 158 422 125
2021/20222.035 59 215 137 108 61 212 85 87 156 180 94 641
2022/20232.848 259 174 83 404 276 638 195 182 226 13 306 92
2023/2024735 122 34 69 34 96 153 107 62 18 20 20 0
Totale 64.495